Summary
Thermo Fisher Scientific Inc. (TMO) has filed an 8-K report on January 31, 2024, to announce its financial results for the fiscal quarter and full year ended December 31, 2023. The key details of these results are provided in a press release furnished as Exhibit 99.1 to this filing. Investors should review this press release for specific figures related to revenue, earnings, and other financial performance indicators. While this 8-K filing itself is primarily a notification of the earnings release, it directs investors to the accompanying press release for comprehensive financial data. This includes information on the company's operational performance, financial condition, and likely forward-looking statements or guidance. Investors are advised to access Exhibit 99.1 for a detailed understanding of TMO's performance during the reported periods and any implications for future financial trends.
Key Highlights
- 1Thermo Fisher Scientific (TMO) announced its financial results for the fourth quarter and full fiscal year ended December 31, 2023.
- 2The financial results were disclosed via a press release furnished as Exhibit 99.1 to the 8-K filing.
- 3Investors are directed to Exhibit 99.1 for detailed information on the company's performance.
- 4The filing's primary purpose is to report the earnings release event.
- 5Information contained within this 8-K and its exhibits is furnished, not deemed 'filed' under Section 18 of the Exchange Act, unless expressly incorporated by reference into a specific filing.
- 6The filing date is January 30, 2024, with the event date also being January 30, 2024.